Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lybridos versus buspirone alone in women with hypoactive sexual desire disorder
NL-OMON37080Phase 2Active, not recruiting
- Sponsor
- Emotional Brain
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lybridos, buspirone, testosterone in hypoactive sexual desire disorder (HSDD), sponsored by Emotional Brain. Started Aug 2012; status: active, not recruiting.
02
Drugs
Lybridosbuspironetestosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NL-OMON37080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37080.